Award NoticePosted Jul 17, 2025

Notice of Intent to Sole Source

Defense Health Agency · ARMY MED RES ACQ ACTIVITY

Stage
Awarded
NAICS
541380
Value
$4.1M
Solicitation
HT942525D00006
Set-aside
None stated
PSC
AN12
Place
Natick, MA, USA
Contact
Kasey Carroll (kasey.l.carroll.civ@health.mil)

No listed company matched (Materiality N/A)

Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation HT942525D00006 in this department, oldest first.

Early notice
None posted
Solicitation
None posted
Award
  • Jul 17, 2025 · this notice
    Award Notice
    METABOLON, INC. · $4.1M

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Note the winner and the end of the period of performance for the recompete.
  • Follow the agency to see the next notice for this work.

What the notice says

The Government requires an IDIQ contract with Metabolon, Inc. to provide metabolomics analysis services of urine, blood, fecal, saliva and tissue samples. This will be a Firm Fixed Price IDIQ contract. USARIEM requires metabolomics analysis services to support their research study protocols. Metabolomics analyses measure small molecules, known as metabolites, which are present in biological samples (e.g., blood, urine, tissue, etc.). Metabolomics analyses can be done using both targeted and untargeted approaches. Targeted approaches measure a pre-defined suite of metabolites. Untargeted approa… (show all)

ches measure hundreds to thousands of metabolites in a single small volume sample. The major challenge with untargeted approaches is identifying the measured metabolites. Identification requires maintaining an extensive library of metabolites and the analytical information associated with those metabolites (i.e., to match results from the analytical instrument with the metabolite identification) Identification is a time and cost-intensive process for laboratories that do not maintain extensive metabolite libraries, and without proper identification, investigators are often left with meaningless data.Thus, extensive libraries that enable identification of hundreds to thousands of metabolites are critical for extracting meaningful information using small volume samples. USARIEM needs to continue to have a large volume of measured metabolites integrated into interpretable maps of biological pathways in order to extract meaningful information from their analysis. Metabolon can provide this service. The most critical aspects of these metabolomics analysis services are the: ? Ability to conduct both untargeted and targeted metabolite analysis. ? Access to an extensive library of over 4,000 known metabolites and ability to accurately identify more than 1,000 metabolites in a small volume sample ? Expertise in utilizing ultra-high performance liquid chromatography/tandem high resolution/accurate mass spectrometry for identifying metabolites in biological samples across multiple chemical classes ? Expertise in bioinformatics and pathway analysis of metabolomics data ? Laboratory systems that are governed by a set of Standard Operating Procedures that have been reviewed, updated, and include quality control steps ? Has a documented history of contributing to peer-reviewed publications using metabolomics analyses in order to prove and validate current and ongoing protocols. Metabolon, Inc. is the only Company that can meet all of these requirements

Who won similar work

7 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Defense Health Agency), same NAICS 541380.

Single-winner award sizes (7): middle half $108K to $1.3M, median $485K; range $60K to $7.5M.

WinnerAwardsValueLast
WINERGY LLC1$7.5MJul 8, 2025
GEL LABORATORIES LLC1$2.1MSep 23, 2025
BROOKS APPLIED LABS LLC1$494KSep 23, 2026
BABCOCK LABORATORIES, INC.1$485KSep 25, 2026
ENVIRONMENTAL RESOURCE ASSOCIATES, INC.1$134KJun 4, 2025
CRANMER ENGINEERING, INC1$82KSep 29, 2025
Eurofins Analytics, LLC1$60KApr 30, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Latest awards

Competitive landscape

For the 7 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (0 filings)
  • 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 32 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.